Treating Metastatic TNBC: Where Are We Now? Treating Metastatic TNBC: Where Are We Now?

New antibody-drug conjugates are a step in the right direction, but the key to developing effective therapies hinges on identifying the best molecular targets.Medscape Oncology
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Article Source Type: news